Want to join the conversation?
$AMGN said FDA approved Amjevita (adalimumab-atto) for the treatment of seven inflammatory diseases. This includes moderate-to-severe rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, chronic plaque psoriasis, Crohn's disease and ulcerative colitis.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.